Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

The Medicines Company

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.

The Medicines Company

Glenn Sblendorio to retire as president of The Medicines Company

Glenn Sblendorio to retire as president of The Medicines Company Sblendorio was appointed as a director at The Medicines Company in July 2011 and has served in his current roles since February 2012. ... Meanwell said: “Glenn has supported The Medicines Company for more than 14 years and he has been and remains my

Alnylam predicts big things for its PCSK9 inhibitor ALN-PCS

Alnylam predicts big things for its PCSK9 inhibitor ALN-PCS The company has previously indicated that even a once-monthly dosing would give it a "highly competitive position" versus current PCSK9 inhibitors, which are predicted to quickly become blockbuster drugs thanks ... The success in the ongoing phase I

FDA gives the nod to TMC's antiplatelet drug

FDA gives the nod to TMC's antiplatelet drug The Medicines Company (TMC) has finally won US approval for its injectable antiplatelet drug Kengreal for the prevention of blood clots during heart procedures. ... TMC's chef executive Clive Meanwell said recently that the company believes cangrelor

AZ and Takeda drugs should carry heart failure warning

AZ and Takeda drugs should carry heart failure warning Cangrelor go-ahead. Meanwhile, the FDA's advisory committee also voted 9 to 2 in favour of approving The Medicines Company's injectable anticoagulant cangrelor as an adjunct to percutaneous coronary ... The FDA is due to deliver a final decision on

FDA reviewer backs approval of TMC's cangrelor

FDA reviewer backs approval of TMC's cangrelor Claims it offers a small benefit over Sanofi’s Plavix.  . The Medicines Company (TMC) looks on course finally to get approval for its intravenous antiplatelet drug cangrelor in the US after ... disease. . However, for TMC the delay in bringing

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health is an integrated communications agency designed for and inspired by the ever-changing face of healthcare. In London, we...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics